Department of Surgery, Kuma Hospital, Kobe, Japan.
Medical Information Management System, Kuma Hospital, Kobe, Japan.
World J Surg. 2024 Sep;48(9):2132-2141. doi: 10.1002/wjs.12307. Epub 2024 Jul 31.
Papillary thyroid carcinoma (PTC) often extends to adjacent organs. According to the 8th Tumor-Node-Metastasis Classification, extension to the strap muscles was graded as T3b. We investigated the prognostic impact of T3b and the appropriateness of T3b in patients aged ≥55 years who were classified as stage II.
We enrolled 7811 patients with M0 PTC who underwent initial surgery at the Kuma Hospital (Kobe, Japan) between January 2007 and December 2016. Tumor extension was divided into T3b, T4a1 (extension to the tracheal adventitia, tracheal cartilage, esophageal muscle layer, recurrent laryngeal nerve, cricothyroid, and inferior constrictor muscles), and sT4a2 (extension to the subcutaneous soft tissues, tracheal mucosa, esophageal mucosa, internal jugular vein, brachiocephalic vein, larynx, pharynx, and sternocleidomastoid muscle).
In patients ≥55 years, the local recurrence-free survival (LR-FS), distant recurrence-free survival (DR-FS), and cause-specific survival (CSS) rates of T3bN0M0 were significantly poorer than those of T1/T2N0M0 but did not significantly differ from those of T3aN0M0. The LR-FS, DR-FS, and CSS rates of T3b stage II patients did not differ from those of T4a1 stage III patients but were significantly better than those of T4a2 stage III patients. T3b was an independent predictor of local recurrence and distant recurrence but not of death due to carcinoma in the multivariate analysis. In patients aged <55 years with M0 PTC, T3b had no prognostic value in both analyses.
T3bM0 patients are appropriate to be classified as stage II in patients ≥55 years but be kept in stage I in patients <55 years.
甲状腺乳头状癌(PTC)常侵犯邻近器官。根据第 8 版肿瘤-淋巴结-转移分类,颈前肌群侵犯被分级为 T3b。我们研究了 T3b 对≥55 岁患者 II 期患者的预后影响及 T3b 分级的适宜性。
我们纳入了 2007 年 1 月至 2016 年 12 月在日本兵库县神户市 kumahospital 行初始手术的 7811 例 M0 PTC 患者。肿瘤侵犯被分为 T3b、T4a1(侵犯气管外膜、气管软骨、食管肌层、喉返神经、环甲、及下缩肌)和 sT4a2(侵犯皮下软组织、气管黏膜、食管黏膜、颈内静脉、头臂静脉、喉、咽及胸锁乳突肌)。
在≥55 岁的患者中,T3bN0M0 的局部无复发生存(LR-FS)、远处无复发生存(DR-FS)和肿瘤特异性生存(CSS)率显著低于 T1/T2N0M0,但与 T3aN0M0 无显著差异。T3b 期 II 患者的 LR-FS、DR-FS 和 CSS 率与 T4a1 期 III 患者无差异,但显著优于 T4a2 期 III 患者。在多变量分析中,T3b 是局部复发和远处复发的独立预测因素,但不是癌死亡的独立预测因素。在<55 岁的 M0 PTC 患者中,T3b 在两项分析中均无预后价值。
T3bM0 患者在≥55 岁患者中适宜被分类为 II 期,但在<55 岁患者中应保留在 I 期。